ã¯ã¦ãªã°ã«ã¼ãã®çµäºæ¥ã2020å¹´1æ31æ¥(é)ã«æ±ºå®ãã¾ãã 以ä¸ã®ã¨ã³ããªã®éããä»å¹´æ«ãç®å¦ã«ã¯ã¦ãªã°ã«ã¼ããçµäºäºå®ã§ããæ¨ããç¥ãããã¦ããã¾ããã 2019å¹´æ«ãç®å¦ã«ãã¯ã¦ãªã°ã«ã¼ãã®æä¾ãçµäºããäºå®ã§ã - ã¯ã¦ãªã°ã«ã¼ãæ¥è¨ ãã®ãã³ãæ£å¼ã«çµäºæ¥ã決å®ãããã¾ããã®ã§ã以ä¸ã®éãã確èªãã ããã çµäºæ¥: 2020å¹´1æ31æ¥(é) ã¨ã¯ã¹ãã¼ãå¸æç³è«æé:2020å¹´1æ31æ¥(é) çµäºæ¥ä»¥éã¯ãã¯ã¦ãªã°ã«ã¼ãã®é²è¦§ããã³æ稿ã¯è¡ãã¾ãããæ¥è¨ã®ã¨ã¯ã¹ãã¼ããå¿ è¦ãªæ¹ã¯ä»¥ä¸ã®è¨äºã«ãããã£ã¦æç¶ãããã¦ãã ããã ã¯ã¦ãªã°ã«ã¼ãã«æ稿ãããæ¥è¨ãã¼ã¿ã®ã¨ã¯ã¹ãã¼ãã«ã¤ã㦠- ã¯ã¦ãªã°ã«ã¼ãæ¥è¨ ãå©ç¨ã®ã¿ãªãã¾ã«ã¯ãè¿·æãããããããã¾ãããã©ãããããããé¡ããããã¾ãã 2020-06-25 è¿½è¨ ã¯ã¦ãªã°ã«ã¼ãæ¥è¨ã®ã¨ã¯ã¹ãã¼ããã¼ã¿ã¯2020å¹´2æ28
å¿ããªãçºã«/å ã¯å¿ã®ç æ°ãèªéçã®å ã ã§ããæ¬å½ã¯è¦ããã£ããã¤ããã£ãã ãã¿ããã£ããçãããã£ãã ã§ããã®è¨èãè¨ã£ã¦ã¯ãããªãã¨æã£ã¦ãã¾ããã 2000å¹´ã®ãã¨ãã ããä»ããï¼å¹´ã»ã©åã«ãªããã§ãããããã¡ãã£ã¨ãããèªããããã¾ãã¦ããã®ãèªãã£ã¦ã¤ãã§ããæ²ç¤ºæ¿ãé²è¦§ã«è¡ã£ã¦ãããã«ã¯ç®ãè¦ããããªãå æ¯ã£ã¦ã®ããã£ãã é害å ã®è¦ªã®å人ãµã¤ãã®æ²ç¤ºæ¿ãããã®ç®¡çè ã¯ä¸ã®åã«ãªãåãæµç£ããã°ãããããã«ãããã ãå ã®æ¸ãè¾¼ã¿ãå ¥ã£ãããã§ãããèªåã¯ãããã ãã¨ãã¦è¦å´ãããã ããä¸ã®åã£ã¦ã®ã¯ä½ããªãã§æ¬²ãããã¨ã ããããå¿åã®æ稿ãç«å ´ã¯å§ãæç« ãã¾ãä¹±æ´ã¨ããã°ä¹±æ´ãªæãã§ã¯ãã£ãã ã ãã©ãç®ãè¦ããããªãå æ¯ãã£ã¦ã®ã¯ããã®å¿åã®æ稿ãããªãã£ãã親ã®ç«å ´ã®äººéãã¡ããã£ã¦ããã£ã¦ãã®å§ãè¢ã ããã«ããå æ¯ã ã£ããããã¦ãããã¯ãã®è¢ã ããã«ããä¸äººã¨ãã¦
以åã«ãç´¹ä»ããé度é害å ã®çºéãæ¢ããçæ³ã«é¢ãã¦ãè±å½ã®ãã¹ã³ããªã©ã§å¤§ããåãä¸ããããããã§ãã ãã®è©±é¡ããã£ã¨åãä¸ãã¦ä¸ãã£ã¦ããåå·å çã®ãµã¤ãã«ãã¡ãã¡ã®æ å ±ãã¾ã¨ããã¨ã³ããªãæ²è¼ããã¦ãã¾ãã growth-attenuation treatment ï¼ãã®ï¼ï¼ ã両親ã«ãããµã¤ããããããã§ãã The "Ashley Treatment", Towards a Better Quality of Life for "Pillow Angels" æµ·å¤ãã¥ã¼ã¹ã®å¤§æãµã¤ãããªãã§ãè©ç¹ ã§ãåãä¸ãããã¦ãã¾ããã 人工çå¦ç½®ã«ãã6æ³ã§æé·ãæ¢ããããå°å¥³ã¢ã·ã¥ãªã¼ (ãªãã§ãè©ç¹) å ã®æ°èè¨äºã®ããããç¥ãã¾ããããå°ãå»å¦çã«èª¤ã£ã¦ããé¨åãããããã§ãã å ·ä½çã«ã¯ã6æ³ã®ã¢ã·ã¥ãªã¼ã¡ããã«å¯¾ãã¦åå®®åé¤è¡ãå®æ½ããããã¨ã¹ããã²ã³ï¼å¥³æ§ãã«ã¢ã³ï¼ã®å
軽度çºéé害ã«é¢ãã¦id:n-shikataããããããã³ã渡ããã¦ããã®ã§ããããã¨ãã¨ä½ãç¥ããªãåéã®ä¸ã«ããããæ å ±ãéãã¦ã¿ãã¨è©±ãå¤å²ã«æ¸¡ã£ã¦ãã¾ã£ã¦ä½ãã©ãæ´çãã¦ããã®ãããã¨æéã ããéãã¦ãã¾ãããã¨ãããããã®è¾ºã§ã¢ãããã¦ã¿ã¾ããã¦ãããéä¸ã§æåæ°ã確èªããã1ä¸åãè¶ ãã¦ã¾ããããã¤ããªããé·ããã¦ããã¾ããã çºéé害ãã¨ãã£ã¦ãã¨ã¦ãå¹ ãåºãã§ããåºæ±æ§çºéé害ã«ã¾ã§çµã£ã¦ã¿ã¦ãä¸äººã§çæ´»ãããã¨ãä¸å¯è½ã¨æãããã¬ããçå群ã®ãããªãã®ãããã¾ããããã«ç¥çé害ã軽ãããç¥çé害ãè¦ãããªã軽度çºéé害ã«ã¾ã§çµãã¨ããããå¦ç¿é害(LD)ãã¢ã¹ãã«ã¬ã¼çå群ã注ææ¬ é¥å¤åæ§é害(ADHD)ã®3ã¤ã«ãªãããã§ãã ã§ãã¦ã£ãããã£ã¢ã®è»½åº¦çºéé害ã®é ç®ãèªãã§ã¿ãã¨ããããã¯ç¥è½ææ°ã¯é«ãã®ã ããã©ãé害ã¯è»½ãã¨ã¯éããªãã¨ããå°ã£ã話ãæ¸ãã¦ããã¾ãã ã¤
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
å¦çãå®è¡ä¸ã§ã
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}